Tag Archives: XBI

Top Heal Care Stocks To Watch Right Now

Shutterstock

Total unfunded liabilities in state and local pensions have roughly quintupled in the last decade.

You read that right—not doubled, tripled, or quadrupled—quintupled. That’s nice when it happens on a slot machine, not so nice when it’s money you owe.

You will also notice in the chart that much of that change happened in 2008.

Why was that?

That’s when the Fed took interest rates down to nearly zero, meaning it suddenly took more cash to fund future payments.

According to a 2014 Pew study, only 15 states follow policies that have funded at least 100% of their pension needs. And that estimate is based on the aggressive assumptions of pension funds that they will get their predicted rate of returns (the “discount rate”).

Top Heal Care Stocks To Watch Right Now: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    More importantly, the SPDR S&P Biotech ETF (NYSE:XBI) has proven resilient during the volatility spike and selloff.

    In fact, XBI never closed significantly below its 50-day moving average as investors dumped stocks. That turned out to be a huge tell…

  • [By Ethan Ryder]

    Investors purchased shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) on weakness during trading hours on Wednesday. $147.17 million flowed into the stock on the tick-up and $108.17 million flowed out of the stock on the tick-down, for a money net flow of $39.00 million into the stock. Of all companies tracked, SPDR S&P Biotech ETF had the 22nd highest net in-flow for the day. SPDR S&P Biotech ETF traded down ($2.97) for the day and closed at $85.44

  • [By ]

    More importantly, the SPDR S&P Biotech ETF (NYSE:XBI) has proven resilient during the volatility spike and selloff.

    In fact, XBI never closed significantly below its 50-day moving average as investors dumped stocks last week.

  • [By ]

    Remember the SPDR S&P Biotech ETF (NYSE:XBI) chart I showed you Friday? Take a look at this ETF bouncing off its 50-day moving average one more time:

  • [By Joe Tenebruso]

    In this regard, two biotech ETFs — the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) and the SPDR S&P Biotech ETF (NYSEMKT:XBI) — stand out among the rest as particularly strong investment options. Read on to learn more about them.

Top Heal Care Stocks To Watch Right Now: Simpson Manufacturing Company Inc.(SSD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Simpson Manufacturing (SSD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Simpson Manufacturing (SSD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Northern Trust Corp lowered its stake in shares of Simpson Manufacturing (NYSE:SSD) by 0.1% in the first quarter, HoldingsChannel reports. The firm owned 1,268,384 shares of the construction company’s stock after selling 968 shares during the period. Northern Trust Corp’s holdings in Simpson Manufacturing were worth $73,047,000 at the end of the most recent reporting period.

  • [By Motley Fool Transcribers]

    Simpson Manufacturing Inc  (NYSE:SSD)Q4 2018 Earnings Conference CallFeb. 04, 2019, 5:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    TRADEMARK VIOLATION WARNING: “Simpson Manufacturing (SSD) Scheduled to Post Quarterly Earnings on Monday” was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at www.tickerreport.com/banking-finance/4119408/simpson-manufacturing-ssd-scheduled-to-post-quarterly-earnings-on-monday.html.

Top Heal Care Stocks To Watch Right Now: Lifetime Brands Inc.(LCUT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Stanley Black & Decker (NYSE: SWK) and Lifetime Brands (NASDAQ:LCUT) are both industrial products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk.

  • [By Ethan Ryder]

    Headlines about Lifetime Brands (NASDAQ:LCUT) have been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Lifetime Brands earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave headlines about the company an impact score of 49.3717790934575 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 10 Value Stocks To Watch For 2019

At $76.77, Best Buy (BBY) a Strong Buy based on the most current relative pricing of its shares and news. The Strong Buy recommendation for Best Buy Inc (NYSE:BBY) resulted from an analytical process that is proprietary which yielded outcomes that were above average in 4 areas: an industry group ranked above average in attractiveness, a ranking in its sector group that is in the top decile, ranking in its industry group that is in the top half, and a quantitative risk/reward calculation that is very attractive; and produced below average conclusions in 2 areas: an economic sector rated below average in attractiveness, and an analytical score that is near average. BBY has recently seen its Portfolio Grader rating upgraded from a Buy to a Strong Buy.

BBY is a constituent of the 5 company Electronics/Appliance Stores GICS industry group, which is part of the 149 company GICS Retail Trade sector. BBY’s market value is $22.5 billion which falls in the top 25% of its industry group BBY’s current Portfolio Grader score places it 2 among the 5 companies in this industry group.

Top 10 Value Stocks To Watch For 2019: Brown Forman Corporation(BF.B)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brown-Forman Co. Class B (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Brown-Forman Co. Class B (NYSE:BF.B) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided EPS guidance of $1.75-1.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.83. The company issued revenue guidance of $3.44-3.48 billion (+6-7%), compared to the consensus revenue estimate of $3.46 billion.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Watch For 2019: Eaton Vance Short Diversified Income Fund(EVG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    EATON VANCE SHO/COM (NYSE:EVG) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Investors of record on Friday, September 21st will be paid a dividend of 0.065 per share on Friday, September 28th. This represents a $0.78 dividend on an annualized basis and a yield of 6.06%. The ex-dividend date is Thursday, September 20th.

Top 10 Value Stocks To Watch For 2019: Performant Financial Corporation(PFMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Performant Financial Corporation (NASDAQ: PFMT) were down 29 percent to $2.20. Performant Financial is expected to release Q1 earnings on May 8.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

  • [By Joseph Griffin]

    News coverage about Performant Financial (NASDAQ:PFMT) has trended somewhat positive on Monday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Performant Financial earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave news headlines about the business services provider an impact score of 48.418433643407 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 10 Value Stocks To Watch For 2019: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Boyer & Corporon Wealth Management LLC decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 64,434 shares of the exchange traded fund’s stock after selling 6,901 shares during the quarter. SPDR S&P Biotech ETF accounts for about 2.7% of Boyer & Corporon Wealth Management LLC’s investment portfolio, making the stock its 5th largest position. Boyer & Corporon Wealth Management LLC owned approximately 0.11% of SPDR S&P Biotech ETF worth $6,133,000 as of its most recent filing with the SEC.

  • [By Money Morning News Team]

    But the biotech sector crushed the market, with the SPDR S&P Biotech ETF (NYSE: XBI) returning a market-beating 43.36% in 2017, nearly double the broader S&P 500.

  • [By ]

    More importantly, the SPDR S&P Biotech ETF (NYSE:XBI) has proven resilient during the volatility spike and selloff.

    In fact, XBI never closed significantly below its 50-day moving average as investors dumped stocks. That turned out to be a huge tell…

  • [By Jim Crumly]

    Tech stocks were strong today, but biotech really took off on merger and acquisition news; the SPDR S&P Biotech ETF (NYSEMKT:XBI) jumped 2.7%. 

  • [By Jim Crumly]

    Technology was the weakest sector, with biotech and semiconductor stocks in particular having a tough day. The SPDR S&P Biotech ETF (NYSEMKT:XBI) tumbled 3.2% and the iShares PHLX Semiconductor ETF (NASDAQ:SOXX) lost 2.4%.

Top 10 Value Stocks To Watch For 2019: SPDR S&P MidCap 400 ETF (MDY)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Financial Advisory Group lifted its position in shares of SPDR S&P MidCap 400 ETF Trust (NYSEARCA:MDY) by 0.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 92,079 shares of the exchange traded fund’s stock after acquiring an additional 587 shares during the quarter. SPDR S&P MidCap 400 ETF Trust makes up approximately 8.9% of Financial Advisory Group’s portfolio, making the stock its 5th biggest position. Financial Advisory Group owned 0.16% of SPDR S&P MidCap 400 ETF Trust worth $33,836,000 at the end of the most recent reporting period.

  • [By ]

    Yet when it comes to investing, reward often comes from being willing to take on risk. Over the past 10 years, investors who’ve been willing to look at smaller companies have seen much stronger returns than those who’ve stuck with the tried-and-true big names that are more familiar to them. When you look at exchange-traded funds tracking indexes composed of companies of different sizes — SPDR S&P 500 (NYSEMKT: SPY) for large companies, SPDR S&P Midcap 400 (NYSEMKT: MDY) for midsize companies and SPDR S&P SmallCap 600 (NYSEMKT: SLY) for small companies — you can put a number on just how much better smaller stocks have done:

  • [By Max Byerly]

    PNC Financial Services Group Inc. trimmed its holdings in SPDR S&P MidCap 400 ETF (NYSEARCA:MDY) by 1.9% during the 1st quarter, Holdings Channel reports. The firm owned 1,139,465 shares of the exchange traded fund’s stock after selling 22,647 shares during the period. PNC Financial Services Group Inc.’s holdings in SPDR S&P MidCap 400 ETF were worth $389,390,000 as of its most recent filing with the SEC.

  • [By Joseph Griffin]

    Round Table Services LLC increased its position in SPDR S&P MidCap 400 ETF Trust (NYSEARCA:MDY) by 19.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 10,239 shares of the exchange traded fund’s stock after buying an additional 1,642 shares during the period. SPDR S&P MidCap 400 ETF Trust comprises approximately 1.2% of Round Table Services LLC’s holdings, making the stock its 20th largest position. Round Table Services LLC’s holdings in SPDR S&P MidCap 400 ETF Trust were worth $3,635,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Curbstone Financial Management Corp reduced its holdings in SPDR S&P MidCap 400 ETF (NYSEARCA:MDY) by 1.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 41,360 shares of the exchange traded fund’s stock after selling 800 shares during the quarter. SPDR S&P MidCap 400 ETF makes up 4.1% of Curbstone Financial Management Corp’s portfolio, making the stock its 2nd biggest holding. Curbstone Financial Management Corp owned approximately 0.07% of SPDR S&P MidCap 400 ETF worth $14,684,000 as of its most recent SEC filing.

Top 10 Value Stocks To Watch For 2019: Hostess Brands, Inc. (TWNK)

Advisors’ Opinion:

  • [By Logan Wallace]

    Vertical Research assumed coverage on shares of Hostess Brands (NASDAQ:TWNK) in a research report sent to investors on Monday morning. The brokerage issued a buy rating on the stock.

  • [By Joseph Griffin]

    Hostess Brands Inc (NASDAQ:TWNK) has received an average rating of “Hold” from the twelve analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $15.40.

  • [By Logan Wallace]

    News coverage about Hostess Brands (NASDAQ:TWNK) has been trending somewhat positive recently, according to Accern. Accern identifies positive and negative media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Hostess Brands earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.5687166542873 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Money Morning News Team]

    Based in Kansas City, Mo., Hostess Brands Inc. (Nasdaq: TWNK) was founded in 1919 and is best known for global brand names that include Twinkies, Ho Hos, Ding Dongs, Dolly Madison, Zingers, Suzy Q, and Donettes.

Top 10 Value Stocks To Watch For 2019: MutualFirst Financial Inc.(MFSF)

Advisors’ Opinion:

  • [By Logan Wallace]

    MutualFirst Financial, Inc. (NASDAQ:MFSF) – Stock analysts at DA Davidson increased their Q3 2018 earnings per share (EPS) estimates for shares of MutualFirst Financial in a research report issued to clients and investors on Monday, July 30th. DA Davidson analyst K. Reevey now forecasts that the bank will earn $0.68 per share for the quarter, up from their previous forecast of $0.62. DA Davidson has a “Neutral” rating on the stock. DA Davidson also issued estimates for MutualFirst Financial’s Q4 2018 earnings at $0.69 EPS, FY2018 earnings at $2.55 EPS and FY2019 earnings at $2.79 EPS.

  • [By Ethan Ryder]

    Media coverage about MutualFirst Financial (NASDAQ:MFSF) has trended somewhat negative recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MutualFirst Financial earned a news impact score of -0.01 on Accern’s scale. Accern also assigned news articles about the bank an impact score of 47.9474560000459 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on MutualFirst Financial (MFSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MutualFirst Financial (MFSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Watch For 2019: Independence Realty Trust, Inc.(IRT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Independence Realty Trust Inc (NYSE:IRT) has been given a consensus rating of “Buy” by the nine ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $10.75.

  • [By Joseph Griffin]

    BlackRock Inc. grew its position in Independence Realty Trust Inc (NYSE:IRT) by 17.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 14,596,051 shares of the real estate investment trust’s stock after purchasing an additional 2,128,304 shares during the period. BlackRock Inc. owned about 0.17% of Independence Realty Trust worth $150,484,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Independence Realty Trust (IRT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Independence Realty Trust (IRT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Independence Realty Trust Inc (NYSE:IRT) have been given an average recommendation of “Buy” by the nine research firms that are covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $10.88.

Top 10 Value Stocks To Watch For 2019: Vanguard FTSE Europe ETF (VGK)

Advisors’ Opinion:

  • [By Jim Crumly]

    European stocks joined U.S equities in moving higher on rumors that an agreement on auto tariffs may be in the works; the Vanguard FTSE Europe ETF (NYSEMKT:VGK) closed up 1.3%. Emerging markets stocks, however, continued recent weakness, with the Vanguard FTSE Emerging Markets ETF (NYSEMKT:VWO) losing 0.1%.

  • [By Max Byerly]

    Tocqueville Asset Management L.P. raised its stake in Vanguard FTSE Europe ETF (NYSEARCA:VGK) by 8.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 166,329 shares of the exchange traded fund’s stock after buying an additional 12,335 shares during the quarter. Tocqueville Asset Management L.P.’s holdings in Vanguard FTSE Europe ETF were worth $9,336,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Shane Hupp]

    Investors purchased shares of Vanguard FTSE Europe ETF (NYSEARCA:VGK) on weakness during trading on Wednesday. $88.65 million flowed into the stock on the tick-up and $33.76 million flowed out of the stock on the tick-down, for a money net flow of $54.89 million into the stock. Of all stocks tracked, Vanguard FTSE Europe ETF had the 15th highest net in-flow for the day. Vanguard FTSE Europe ETF traded down ($0.94) for the day and closed at $54.60

  • [By Joseph Griffin]

    Round Table Services LLC acquired a new position in Vanguard FTSE Europe ETF (NYSEARCA:VGK) in the second quarter, Holdings Channel reports. The firm acquired 5,122 shares of the exchange traded fund’s stock, valued at approximately $287,000.

Top 10 Value Stocks To Watch For 2019: KLA-Tencor Corporation(KLAC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    JPMorgan Chase & Co. reduced its position in shares of KLA-Tencor Corp (NASDAQ:KLAC) by 29.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,157,739 shares of the semiconductor company’s stock after selling 897,207 shares during the period. JPMorgan Chase & Co. owned approximately 1.38% of KLA-Tencor worth $235,213,000 at the end of the most recent quarter.

  • [By ]

    Kulicke and Soffa Industries (NASDAQ:KLIC) is not a well-known company. The semiconductor packaging equipment specialist is valued at just $1.65 billion, and it recorded just $809 million of revenue last year. That’s a much smaller number than those posted by semiconductor equipment giants like Applied Materials (NASDAQ:AMAT), KLA-Tencor (NASDAQ:KLAC), and Lam Research (NASDAQ:LRCX).

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on KLA-Tencor (KLAC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on KLA-Tencor (KLAC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now

Meet the Annuity Trust on Bernie Sanders Hit List

How to Get Medicaid for Nursing Home Care Without Going Broke

10 States Where the Millennials Are More Obese Than the Seniors

The $475,000 price tag on Novartis AG’s latest breakthrough cancer therapy came under fire from one of the biggest managers of drug costs in the United States, underscoring the challenges the Swiss drugmaker will face in promoting the potential blockbuster.

The cost of the leukemia treatment, called Kymriah, is “dramatically higher” than other such complex treatments, and the health care system isn’t ready to pay for it, Steve Miller, chief medical officer at Express Scripts Holding Co., said Thursday in a blog post on his company’s website. Gene therapies like Novartis’s are targeted at a small number of patients and typically used just once, meaning that drug companies have limited chances to recoup their investment.

“Therein lies the challenge,” Miller wrote. “We need a new payment model.”

Top 10 Medical Stocks To Invest In Right Now: Aqua America, Inc.(WTR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Connecticut Water Service (NASDAQ: CTWS) and Aqua America (NYSE:WTR) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

  • [By ]

    Cramer was bearish on United States Steel (X) , Teva Pharmaceuticals (TEVA) , Aqua America (WTR) and Mueller Water Products (MWA) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Shane Hupp]

    Duff & Phelps Investment Management Co. reduced its stake in shares of Aqua America (NYSE:WTR) by 7.1% during the first quarter, Holdings Channel reports. The institutional investor owned 95,640 shares of the utilities provider’s stock after selling 7,290 shares during the quarter. Duff & Phelps Investment Management Co.’s holdings in Aqua America were worth $3,257,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Aqua America (NYSE:WTR) from a hold rating to a buy rating in a report released on Friday.

    Several other analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of Aqua America from a hold rating to a buy rating and set a $41.00 price objective on the stock in a research report on Monday, January 15th. Wells Fargo downgraded shares of Aqua America from an outperform rating to a market perform rating and dropped their price target for the stock from $43.00 to $37.00 in a research report on Monday, February 26th. UBS began coverage on shares of Aqua America in a research report on Thursday, March 8th. They set a neutral rating and a $36.00 price target on the stock. Finally, Boenning Scattergood restated a neutral rating on shares of Aqua America in a research report on Tuesday, April 24th. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $38.29.

  • [By Joseph Griffin]

    Aqua America (NYSE: WTR) and SJW Group (NYSE:SJW) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

  • [By ]

    Aqua America (WTR) : “This is not the stock for a hot economy, even though this is a well-run company.”

    Mueller Water Products (MWA) : “This is not the time to buy. I don’t like the numbers.”

Top 10 Medical Stocks To Invest In Right Now: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Brian Feroldi]

    For example, I used finvizin the recent past to find a dynamic growth company called HealthEquity (NASDAQ:HQY). I quickly learned that HealthEquity’s revenue and earnings have compounded at 38% and 57%, respectively, over the last five years. Those numbers convinced me to dig deeper and I soon became so excited about the company’s prospects that I purchased shares for myself right away.

  • [By Max Byerly]

    Swiss National Bank grew its holdings in HealthEquity (NASDAQ:HQY) by 3.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,800 shares of the company’s stock after purchasing an additional 2,900 shares during the quarter. Swiss National Bank owned approximately 0.15% of HealthEquity worth $5,376,000 at the end of the most recent quarter.

  • [By Brian Feroldi]

    So where am I going to invest my capital? While I’m still refining my list, here are seven stocks that I currently own that I’m strongly considering adding to:

    Hubspot (NYSE: HUBS) — A software-as-a-service provider that is pioneering the shift toward “inbound” marketing. HealthEquity (NASDAQ: HQY) — A fast-growing company focused on Health Savings Accounts that boasts three sources of recurring revenue. Axon Enterprise (NASDAQ: AAXN) — The leading provider ofTaser stun guns, law enforcement body cameras, and evidence-management software. Paycom Software (NYSE: PAYC) — A founder-ledpayroll-processor company that is gobbling up market share. Adobe Systems (NASDAQ: ADBE)– The company’s push to the cloud is drivingdouble-digitgains in revenue and profits. AppFolio (NASDAQ: APPF) — Asoftware-as-a-service provider focused on servicing business owners in severalniche markets. BlackLine (NASDAQ: BL) — A software company that is attempting to bring the accounting process into the 21st century.

    All seven of these businesses are poised to deliver double-digit organic revenue and profit growth over the next five years. That’s a prospect I find quite enticing, and I think the odds are very favorable that they’ll outperform Apple as a group from here.

  • [By Max Byerly]

    ValuEngine upgraded shares of HealthEquity (NASDAQ:HQY) from a buy rating to a strong-buy rating in a research report report published on Tuesday morning.

  • [By Max Byerly]

    Healthequity Inc (NASDAQ:HQY) – Research analysts at Barrington Research issued their Q2 2019 EPS estimates for shares of Healthequity in a report issued on Tuesday, June 5th. Barrington Research analyst A. Paris. Jr expects that the company will post earnings per share of $0.20 for the quarter. Barrington Research currently has a “Outperform” rating and a $85.00 target price on the stock. Barrington Research also issued estimates for Healthequity’s FY2019 earnings at $0.70 EPS.

Top 10 Medical Stocks To Invest In Right Now: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Stifel Financial Corp cut its stake in shares of Genesis Energy, L.P. common stock (NYSE:GEL) by 1.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 450,749 shares of the pipeline company’s stock after selling 7,788 shares during the quarter. Stifel Financial Corp owned about 0.37% of Genesis Energy, L.P. common stock worth $8,884,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Genesis Energy, L.P. common stock (GEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Blair William & Co. IL cut its stake in Genesis Energy, L.P. common stock (NYSE:GEL) by 21.6% in the first quarter, HoldingsChannel.com reports. The fund owned 55,817 shares of the pipeline company’s stock after selling 15,409 shares during the period. Blair William & Co. IL’s holdings in Genesis Energy, L.P. common stock were worth $1,100,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Medical Stocks To Invest In Right Now: Compass Diversified Holdings(CODI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Schroder Investment Management Group grew its stake in Compass Diversified Holdings (NYSE:CODI) by 3.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,097,576 shares of the financial services provider’s stock after purchasing an additional 33,776 shares during the period. Schroder Investment Management Group owned approximately 1.83% of Compass Diversified worth $18,000,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Invest In Right Now: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

    Get Inogen alerts:

    Comparing Halyard Health (HYH) and Inogen (INGN) (americanbankingnews.com) ‘The stock market has sucked on nitrous oxide’ Wall… (beaumontenterprise.com) EPS Calculations to Consider Inogen Inc (NASDAQ: INGN) (stocksmarketcap.com) Inogen’s shares drop on short seller Citron’s tweet (reuters.com) Inogen Hit By Citron Report; Analyst Rebuttal Calls This ‘An Excellent Entry Point’ (msn.com)

    Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Inogen from $150.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann restated an “outperform” rating and set a $170.00 price target (up from $150.00) on shares of Inogen in a research report on Tuesday, May 1st. ValuEngine upgraded Inogen from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded Inogen from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, February 13th. Finally, BidaskClub upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Friday, March 9th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and three have issued a strong buy rating to the company. Inogen has an average rating of “Buy” and an average target price of $178.00.

  • [By Ethan Ryder]

    Inogen Inc (NASDAQ:INGN) Director Ray Benjamin M. Anderson sold 1,000 shares of the company’s stock in a transaction dated Monday, July 2nd. The stock was sold at an average price of $184.88, for a total value of $184,880.00. Following the completion of the transaction, the director now owns 1,989 shares in the company, valued at $367,726.32. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

  • [By Logan Wallace]

    Rock Springs Capital Management LP lifted its stake in shares of Inogen Inc (NASDAQ:INGN) by 38.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 110,500 shares of the medical technology company’s stock after purchasing an additional 30,500 shares during the quarter. Rock Springs Capital Management LP owned 0.52% of Inogen worth $13,574,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Inogen Inc (NASDAQ:INGN) EVP Byron Myers sold 1,846 shares of the business’s stock in a transaction dated Monday, June 18th. The stock was sold at an average price of $190.04, for a total transaction of $350,813.84. Following the sale, the executive vice president now owns 39,121 shares in the company, valued at $7,434,554.84. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Top 10 Medical Stocks To Invest In Right Now: RELX N.V.(RENX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Relx (RENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: American Financial Group, Inc.(AFG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about American Financial Group (NYSE:AFG) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. American Financial Group earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned press coverage about the insurance provider an impact score of 46.840441381164 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Joseph Griffin]

    Westpac Banking Corp increased its stake in shares of American Financial Group (NYSE:AFG) by 10.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,403 shares of the insurance provider’s stock after purchasing an additional 709 shares during the quarter. Westpac Banking Corp’s holdings in American Financial Group were worth $831,000 as of its most recent filing with the SEC.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on American Financial Group (AFG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: OneMain Holdings, Inc.(OMF)

Advisors’ Opinion:

  • [By Max Byerly]

    Rhumbline Advisers boosted its position in shares of OneMain Holdings Inc (NYSE:OMF) by 18.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,772 shares of the financial services provider’s stock after acquiring an additional 9,479 shares during the period. Rhumbline Advisers’ holdings in OneMain were worth $1,790,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Max Byerly]

    OneMain (NYSE: OMF) and Provident Financial (OTCMKTS:FPLPY) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OneMain (OMF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    In a sea of red, small-cap biotech stocks stood strong during Wednesdays trading session. The SPDR S&P Biotech ETF (NYSE:XBI) finished the day higher by more than 1.25% while the Nasdaq Composite was stuck in the red. XBIs comeback rally that began to materialize just before Christmas is now threatening to break out to new highs.

  • [By Money Morning News Team]

    But the biotech sector crushed the market, with the SPDR S&P Biotech ETF (NYSE: XBI) returning a market-beating 43.36% in 2017, nearly double the broader S&P 500.

  • [By Jim Crumly]

    Technology was the weakest sector, with biotech and semiconductor stocks in particular having a tough day. TheSPDR S&P Biotech ETF (NYSEMKT:XBI) tumbled 3.2% and theiShares PHLX Semiconductor ETF (NASDAQ:SOXX) lost 2.4%.

  • [By ]

    More importantly, the SPDR S&P Biotech ETF (NYSE:XBI) has proven resilient during the volatility spike and selloff.

    In fact, XBI never closed significantly below its 50-day moving average as investors dumped stocks. That turned out to be a huge tell

Top 10 Medical Stocks To Invest In Right Now: Energy Fuels Inc(UUUU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Old West Investment Management LLC purchased a new stake in Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) in the first quarter, HoldingsChannel reports. The firm purchased 578,496 shares of the basic materials company’s stock, valued at approximately $1,003,000.

  • [By Stephan Byrd]

    Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR) shares saw an uptick in trading volume on Monday . 1,091,365 shares were traded during mid-day trading, an increase of 300% from the previous session’s volume of 272,846 shares.The stock last traded at $2.09 and had previously closed at $2.04.

  • [By Stephan Byrd]

    Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 2,265,513 shares, an increase of 19.6% from the May 31st total of 1,893,582 shares. Based on an average daily volume of 589,166 shares, the days-to-cover ratio is presently 3.8 days. Approximately 3.3% of the shares of the stock are short sold.

Top Bank Stocks To Buy Right Now

Related SPY DC Insider Reveals The Hottest Topic On The RNC's Agenda The Market In 5 Minutes Mraz, Amerine & Associates, Inc. Buys NOW Inc, Antero Resources Corp, JPMorgan Chase, Sells … (GuruFocus)

The financial crisis of 2008 that devastated millions of Americans and continues to haunt the country’s economy had several root causes. Fraud, bankers recklessly gambling on toxic assets and other Wall Street malfeasance reached a nadir that wiped out many people’s financial futures and changed the course of American politics.

Top Bank Stocks To Buy Right Now: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Chris Lange]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI).

  • [By Lisa Levin]

    Shares of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) got a boost, shooting up 32 percent to $12.40 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients with disease progression on or after PD-1 therapies.

Top Bank Stocks To Buy Right Now: SanDisk Corporation(SNDK)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Early on Friday, analysts at RBC Capital boosted the near-term estimates on SanDisk Corporation (SNDK), a manufacturer of data storage products, because a fire at SK Hynix’s factory should lead to favorable pricing over the next two quarters.

    “We see a favorable pricing environment as a result of SK Hynix’s fire, which threatens to curtail NAND output as the company likely re-purposes production back toward DRAM, resulting in lower than expected incremental NAND wafers vs. company’s plan of 170K/WPM,” RBC Capital analyst Freedman said. “Consequently, we see stronger pricing through EoY before SK Hynix ramps NAND toward normalized prod’t levels as DRAM resources are restored/replaced.”

    The analysts maintain an “Outperform” rating on SDNK and still see shares reaching $76. This price target suggests a 26% upside to the stock’s Thursday closing price of $60.08. Furthermore, they boosted SanDisk’s 2013 EPS estimates from $4.82 to $4.95.

    SanDisk shares were up a fraction during pre-market trading on Friday. The stock is up 38.11% year-to-date.

Top Bank Stocks To Buy Right Now: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By ]

    In a sea of red, small-cap biotech stocks stood strong during Wednesdays trading session. The SPDR S&P Biotech ETF (NYSE:XBI) finished the day higher by more than 1.25% while the Nasdaq Composite was stuck in the red. XBIs comeback rally that began to materialize just before Christmas is now threatening to break out to new highs.

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

  • [By Money Morning News Team]

    But the biotech sector crushed the market, with the SPDR S&P Biotech ETF (NYSE: XBI) returning a market-beating 43.36% in 2017, nearly double the broader S&P 500.

  • [By ]

    More importantly, the SPDR S&P Biotech ETF (NYSE:XBI) has proven resilient during the volatility spike and selloff.

    In fact, XBI never closed significantly below its 50-day moving average as investors dumped stocks. That turned out to be a huge tell

Top Bank Stocks To Buy Right Now: HTG Molecular Diagnostics, Inc.(HTGM)

Advisors’ Opinion:

  • [By Lisa Levin]

    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares were also up, gaining 136 percent to $2.95. HTG Molecular Diagnostics disclosed that its new direct-target sequencing chemistry will be launched in the first quarter.

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Lisa Levin] Related HTGM 20 Biggest Mid-Day Losers For Thursday 25 Stocks Moving In Thursday's Pre-Market Session HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU (GuruFocus)
    Related SSH 15 Biggest Mid-Day Gainers For Wednesday 12 Biggest Mid-Day Losers For Tuesday Healthcare – Top 5 Gainers / Losers as of 11:00 am (Seeking Alpha) Gainers
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 63.6 percent to $3.50 in pre-market trading after the company disclosed that it has obtained CE marking in the EU for HTG EdgeSeq ALKPlus Assay.
    Sunshine Heart Inc (NASDAQ: SSH) rose 20.3 percent to $2.61 in pre-market trading after the company issued a business update regarding execution of its strategic growth plan.
    bebe stores, inc. (NASDAQ: BEBE) shares rose 11.1 percent to $4.29 in pre-market trading after the company disclosed that it is exploring strategic alternatives.
    Cancer Genetics Inc (NASDAQ: CGIX) rose 10.3 percent to $3.20 in pre-market trading after the company posted a narrower-than-expected quarterly loss.
    Five Below Inc (NASDAQ: FIVE) rose 8.8 percent to $41.50 in pre-market trading after the company reported better-than-expected earnings for its fourth quarter.
    FireEye Inc (NASDAQ: FEYE) rose 8 percent to $12.40 in pre-market trading. Goldman Sachs upgraded FireEye from Sell to Buy.
    PVH Corp (NYSE: PVH) shares rose 7.4 percent to $97.60 in pre-market trading after the company posted upbeat earnings for its fourth quarter and issued a strong earnings forecast.
    Bitauto Hldg Ltd (ADR) (NASDAQ: BITA) shares rose 7 percent to $26.00 in pre-market trading after dropping 1.30 percent on Wednesday.
    Pingtan Marine Enterprise Ltd (NASDAQ: PME) rose 6.6 percent to $4.50 in pre-market trading after gaining 0.48 pe

Top Bank Stocks To Buy Right Now: Eastman Kodak Company(KODK)

Advisors’ Opinion:

  • [By William Patalon III]

    The first trade spat that I covered during my newspaper days was one back in the mid-1990s that pitted Eastman Kodak Co. (NYSE: KODK) against Fujifilm Holdings Corp. (OTC ADR: FUJIY).

  • [By Lee Jackson]

    Another famous American company caught a seller last week. Eastman Kodak Co.(NYSE: KODK) had a 10% owner selling shares. Blue Mountain Capital sold a total of 1,353,653 shares, and prices ranged from $11.54 to $11.75 a share. The total for the sale was set at $16 million. The shares closed Friday at $11.50, in a 52 week range of $10 to $17.30. There was no consensus target as the stock is not followed on Wall Street.

  • [By ]

    Even Kodak (NYSE: KODK) is on the blockchain bandwagon.

    Shares of the print and film company spiked more than 328% in the two-day period ending January 10, 2018.

  • [By ]

    Eastman Kodak Co. (NYSE:KODK) surprised investors earlier this month when the company announced it was planning to launch its own cryptocurrency.

    Speculators quickly scooped up Kodaks languishing stock on the news, sending shares from $3 to more than $13 in just two trading days.

Top Bank Stocks To Buy Right Now: Canterbury Park Holding Corporation(CPHC)

Advisors’ Opinion:

  • [By Sally Jones]

    Canterbury Park Holding Corporation (CPHC) Market Cap $46.35 Million

    Canterbury Park Holding Corporation is up 2% over 12 months. The company has a market cap of $46.35 million; its trades around $11.16 with a P/E ratio of 59.30 and a P/B of 1.70.

Hot Warren Buffett Stocks To Buy For 2018

>

Popular Posts: 7 Hot Stocks to Buy for High-Momentum Gains7 Companies Warren Buffett Should BuyNow3 Small-Cap Stocks With Sizable Dividends
Recent Posts:

Forget Snap Inc (SNAP) Stock, Buy Snap-on Incorporated (SNA) Instead Could the New Rite Aid Corporation (RAD) Go Broke? 7 Hot Stocks to Buy for High-Momentum Gains View All Posts

Take the “P” off Snap Inc’s (NYSE:SNAP) stock symbol, and you get Snap-on Incorporated (NYSE:SNA), what I consider the better buy among two beaten-down stocks.

Hot Warren Buffett Stocks To Buy For 2018: Brookline Bancorp Inc.(BRKL)

Advisors’ Opinion:

  • [By Dividends4Life]

    Memberships and Peers: PBCT is a member of the S&P 500 and a member of the Broad Dividend Achievers Index. The company’s peer group includes: Bank of America Corporation (BAC) with a 0.3% yield, Brookline Bancorp, Inc. (BRKL) with a 3.7% yield and Westfield Financial Inc. (WFD) with a 3.5% yield.

Hot Warren Buffett Stocks To Buy For 2018: Federated Investors, Inc.(FII)

Advisors’ Opinion:

  • [By Gregg Greenberg]

     Stocks of Federated Investors (FII) fell approximately 9% in 2015, yet Oja expects a big turnaround in 2016, once again due to the prospect of higher rates ahead. 

     

    "The money market fund business, which is unprofitable now, should become more profitable as rates rise because Federated has to reimburse for the servicing fees for these funds," said Oja, who also admires the fund company’s 3.5% dividend yield. 

     

    Oja added that Federated also has a "good core business of equity and fixed-income asset management." 

Hot Warren Buffett Stocks To Buy For 2018: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    Fast forward 12 months and the SPDR S&P Biotech ETF (NYSE:XBI) is higher by almost 50%. But this rally aint over yet. The beginning of 2018 trading is already flashing a new biotech breakout a move that could cement these stocks as some of the years most explosive market leaders.

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By ]

    And while the big drug companies will experience a significant adjustment, biotech companies, with their focus on long term results and outright cures in some cases, are probably poised to perform. The best way to get invested would be with the Biotech Spider ETF (NYSE: XBI).

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).